Additional Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Dr. Georges-L.-Dumont University Hospital Centre
    Moncton NB. E1C 2Z3
    View Details
  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    QEII Health Sciences Centre
    Halifax NS. B3H 3A7
    View Details
  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details
  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Tampa General Hospital Center of Research Excellence
    Tampa FL. 33606
    View Details
  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Medical University of South Carolina
    Charleston SC. 29425
    View Details
  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    UCSF
    San Francisco CA. 94143
    View Details
  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    UC Davis
    Sacramento CA. 95817
    View Details
  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Houston Methodist
    Houston TX. 77030
    View Details
  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Hartford Hospital
    Hartford CT. 06102
    View Details
  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    UCLA Westwood
    Los Angeles CA. 90095
    View Details
  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    NYU Langone Medical Center
    New York NY. 10016
    View Details
  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    University of Utah
    Salt Lake City UT. 84112
    View Details
  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Norton Pulmonary Specialists
    Louisville KY. 40241
    View Details
  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    University of Michigan
    Ann Arbor MI. 48109
    View Details
  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Arizona Pulmonary Specialists
    Phoenix AZ. 85012
    View Details
  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Summit Health
    Bend OR. 97701
    View Details
  • An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

    Vincent Medical Group
    Indianapolis IN. 46260
    View Details
  • Efficacy and Safety Study of OATD-01 in Patients with Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Kansas City KS. 66062
    View Details
  • Efficacy and Safety Study of OATD-01 in Patients with Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Charleston SC. 29425
    View Details
  • Efficacy and Safety Study of OATD-01 in Patients with Active Pulmonary Sarcoidosis

    Molecure Investigative Site
    Birmingham AL. 35209
    View Details